Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Phospho-Proteomic Profiling of T-Cell Acute Lymphoblastic Leukemia Identifies Specific Kinase Activation Signatures That Can Predict Response to Targeted Therapy

Valentina Cordo', MSc, Rico Hagelaar, Sander Piersma, Thang V Pham, Connie Jimenez, PhD, Jules P.P. Meijerink, PhD

Blood (2019) 134 (Supplement_1): 4649.

https://doi.org/10.1182/blood-2019-122898

Published: 2019

Journal Articles

Gut Microbiome Changes after Stem Cell Transplantation

Patrizia Chiusolo, Elisabetta Metafuni, Francesco Paroni Sterbini, Sabrina Giammarco, Luca Masucci, Giuseppe Leone, MD, Simona Sica

Blood (2015) 126 (23): 1953.

https://doi.org/10.1182/blood.V126.23.1953.1953

Published: 2015

Journal Articles

Backtracking Subclonal Mutations Of TP53 In Myelodysplasia (MDS) With Del(5q) With Next-Generation Sequencing (NGS)

Blood (2013) 122 (21): 520.

https://doi.org/10.1182/blood.V122.21.520.520

Published: 2013

Journal Articles

A Targeted Resequencing Study Allows the Detection of a Common Polymorphism At Mirna-223 Binding Site in 3′Untranslated Region Which Deregulates HSP90B1 Expression in Chronic Lymphocytic Leukemia

Ana E Rodríguez, Dalia Qwaider, Rocío Benito, PhD, Irena Misiewicz-Krzeminska, María Hernández-Sánchez, M Eugenia Sarasquete, Jesús F San Miguel, MD, Jose Ángel Hernández-Rivas, Norma Gutierrez, Jesús M Hernández-Rivas

Blood (2012) 120 (21): 1776.

https://doi.org/10.1182/blood.V120.21.1776.1776

Published: 2012

Journal Articles

Kings Health Partners 17 Gene Amplicon Panel for Next Generation Sequencing One Stop Mutational Assessment In Myeloid Malignancies

Nicholas C Lea, PhD, Atiyeh Abdallah, PhD, Aytug Kizilors, PhD, Alexander E Smith, PhD, Syed A Mian, Azim M Mohamedali, PhD, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath

Blood (2011) 118 (21): 748.

https://doi.org/10.1182/blood.V118.21.748.748

Published: 2011

Journal Articles

Functional Characterization of CD4 + T-Cells in Aplastic Anemia (AA)

Shahram Y Kordasti, MD, PhD, Judith C. W. Marsh, Prof MD PhD, Sufyan Al-Khan, MD, Jie Jiang, PhD, Alexander E Smith, PhD, Azim M Mohamedali, PhD, Pilar Perez Abellan, Caroline Veen, Benedetta Costantini, MD, Nana Benson Quarm, Thomas Seidl, Syed A Mian, Farzin Farzaneh, DPhil, Ghulam J. Mufti, MD

Blood (2011) 118 (21): 1340.

https://doi.org/10.1182/blood.V118.21.1340.1340

Published: 2011

Journal Articles

Assessment of Multiple Myeloma IGHV Intraclonal Variation by Massively Parallel Pyrosequencing

Renee C. Tschumper, Yan W. Asmann, Ph.D., Asif Hossain, Paul M. Huddleston, M.D., Xiaosheng Wu, M.D., Angela Dispenzieri, MD, Bruce W. Eckloff, Diane F. Jelinek, Ph.D.

Blood (2011) 118 (21): 1814.

https://doi.org/10.1182/blood.V118.21.1814.1814

Published: 2011

Journal Articles

Analyses of 81 Chronic Myelomonocytic Leukemia (CMML) for EZH2 , TET2 , ASXL1 , CBL , KRAS , NRAS , RUNX1 , IDH1 , IDH2 , and NPM1 Revealed Mutations In 86.4% of All Patients with TET2 and EZH2 Being of High Prognostic Relevance

Vera Grossmann, MA, Alexander Kohlmann, PhD, Christiane Eder, PhD, Nicholas C.P. Cross, PhD, FRCPath, Claudia Haferlach, MD, Wolfgang Kern, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD

Blood (2010) 116 (21): 296.

https://doi.org/10.1182/blood.V116.21.296.296

Published: 2010

Journal Articles

Ultra-Deep Next-Generation Sequencing (NGS) Detects BCR - ABL1 Kinase Domain Mutations with High Sensitivity and Allows to Monitor the Composition of Distinct Subclones During Tyrosine Kinase Inhibitor Treatment

Vera Grossmann, MA, Melanie Wild, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD, Alexander Kohlmann, PhD

Blood (2010) 116 (21): 2268.

https://doi.org/10.1182/blood.V116.21.2268.2268

Published: 2010

Journal Articles

A Comprehensive Deep-Sequencing Study of Blast Crisis Chronic Myeloid Leukemia (CML) Reveals New Insights Into Molecular Heterogeneity and Detects Mutations In 12 Different Genes In 82.5% of Cases

Vera Grossmann, MA, Christiane Eder, PhD, Sonja Schindela, Alexander Kohlmann, PhD, Sandra Wille, PhD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Martin C. Müller, Andreas Hochhaus, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2010) 116 (21): 884.

https://doi.org/10.1182/blood.V116.21.884.884

Published: 2010

Journal Articles

Whole Kinome Profiling In Pediatric Acute Leukemia.

Michael Gombert, PhD, Pina Fanny Ida Krell, MSc, René Martin Linka, PhD, Stefan Knapp, PhD, Arndt Borkhardt, MD

Blood (2010) 116 (21): 1029.

https://doi.org/10.1182/blood.V116.21.1029.1029

Published: 2010

Journal Articles

Ultra-Deep Next-Generation Sequencing Detects RUNX1 Mutations with Unprecedented Sensitivity and Allows to Monitor Minimal Residual Disease In 116 Samples From MDS and AML Patients

Alexander Kohlmann, PhD, Vera Grossmann, MA, Sonja Schindela, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD

Blood (2010) 116 (21): 1691.

https://doi.org/10.1182/blood.V116.21.1691.1691

Published: 2010

Journal Articles

Robust and Sensitive Detection of Insertions, Deletions and Point Mutations In CEBPA , a GC-Rich Content Gene, Using 454 Next-Generation Deep-Sequencing (NGS).

Vera Grossmann, MA, Susanne Schnittger, PhD, Sonja Schindela, Hans-Ulrich Klein, MA, Christiane Eder, PhD, Martin Dugas, MD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD, Alexander Kohlmann, PhD

Blood (2010) 116 (21): 1657.

https://doi.org/10.1182/blood.V116.21.1657.1657

Published: 2010

Journal Articles

Targeted Next-Generation Sequencing (NGS) Enables a Broad Screening of 95 Molecular Mutations In a One-Step Approach and Detects Recurrent Mutations In AML with a Normal Karyotype In MYH11 and NOTCH1

Alexander Kohlmann, PhD, Vera Grossmann, MA, Hans-Ulrich Klein, MA, Susanne Schnittger, PhD, Martin Dugas, MD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2010) 116 (21): 175.

https://doi.org/10.1182/blood.V116.21.175.175

Published: 2010

Journal Articles

The Interlaboratory RObustness of Next-Generation Sequencing (IRON) Study: Deep-Sequencing Investigating TET2 , CBL , and KRAS Mutations In 4464 Amplicons by An International Group Involving 8 Laboratories.

Blood (2010) 116 (21): 1665.

https://doi.org/10.1182/blood.V116.21.1665.1665

Published: 2010

Journal Articles

Landscape of TET2 Mutations In Acute Myeloid Leukemia (AML): A Next-Generation Sequencing Study Investigating 76 Cases Comprehensively Characterized for Cytogenetics and Other Molecular Markers.

Sandra Wille, PhD, Vera Grossmann, MA, Tamara Alpermann, Claudia Haferlach, MD, Wolfgang Kern, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD, Alexander Kohlmann, PhD

Blood (2010) 116 (21): 1035.

https://doi.org/10.1182/blood.V116.21.1035.1035

Published: 2010

Journal Articles

Clinical, Histomorphometric and Radiographic Evaluation of Dental Extraction Sockets Treated with Autologous Stem Cells

André Pelegrini, DDS, PhD, Maria Elvira P Corrêa, DDS, PhD, Thiago Oliveira, DDS, Carmino De Souza, MD, PhD, José Francisco Marques, MD, PhD

Blood (2010) 116 (21): 2398.

https://doi.org/10.1182/blood.V116.21.2398.2398

Published: 2010

Journal Articles

Next-Generation Sequencing (NGS) in CMML, MDS and AML Detects Molecular Mutations in Oncogenes and Allows the Identification of Balanced Chromosomal Abnormalities with Extraordinary Sensitivity and Specificity.

Vera Grossmann, MA, Alexander Kohlmann, PhD, Claudia Haferlach, MD, Hans-Ulrich Klein, MA, Martin Dugas, MD, Frank Dicker, PhD, Beray Kazak, Sonja Schindela, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2009) 114 (22): 144.

https://doi.org/10.1182/blood.V114.22.144.144

Published: 2009

Journal Articles

Targeted Next-Generation Sequencing (NGS) Enables for the First Time the Detection of Point Mutations, Molecular Insertions and Deletions, as Well as Leukemia-Specific Fusion Genes in AML in a Single Procedure.

Alexander Kohlmann, PhD, Vera Grossmann, MA, Hans-Ulrich Klein, Sonja Schindela, Martin Dugas, MD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2009) 114 (22): 706.

https://doi.org/10.1182/blood.V114.22.706.706

Published: 2009

Journal Articles

Construction of An Outpatient Erythrocytapheresis Program for Pediatric Patients with Sickle Cell Disease

Paulette Bryant, MD, Richard Parmley, MD, Christine Bolen, MD, Theresa Sunderland, MD, Robert Johnson, MD, Jennifer Weisner, PNP, Karen Nishioka, BSN, Karen Roberts, RN, Richard Towell, RN, Jodi P. Strong, MBA, Evelyn Lockhart, MD, Mark Mogul, MD

Blood (2008) 112 (11): 4067.

https://doi.org/10.1182/blood.V112.11.4067.4067

Published: 2008

NARROW

Phospho-Proteomic Profiling of T-Cell Acute Lymphoblastic Leukemia Identifies Specific Kinase Activation Signatures That Can Predict Response to Targeted Therapy

Gut Microbiome Changes after Stem Cell Transplantation

Backtracking Subclonal Mutations Of TP53 In Myelodysplasia (MDS) With Del(5q) With Next-Generation Sequencing (NGS)

A Targeted Resequencing Study Allows the Detection of a Common Polymorphism At Mirna-223 Binding Site in 3′Untranslated Region Which Deregulates HSP90B1 Expression in Chronic Lymphocytic Leukemia

Kings Health Partners 17 Gene Amplicon Panel for Next Generation Sequencing One Stop Mutational Assessment In Myeloid Malignancies

Functional Characterization of CD4 + T-Cells in Aplastic Anemia (AA)

Assessment of Multiple Myeloma IGHV Intraclonal Variation by Massively Parallel Pyrosequencing

Analyses of 81 Chronic Myelomonocytic Leukemia (CMML) for EZH2 , TET2 , ASXL1 , CBL , KRAS , NRAS , RUNX1 , IDH1 , IDH2 , and NPM1 Revealed Mutations In 86.4% of All Patients with TET2 and EZH2 Being of High Prognostic Relevance

Ultra-Deep Next-Generation Sequencing (NGS) Detects BCR - ABL1 Kinase Domain Mutations with High Sensitivity and Allows to Monitor the Composition of Distinct Subclones During Tyrosine Kinase Inhibitor Treatment

A Comprehensive Deep-Sequencing Study of Blast Crisis Chronic Myeloid Leukemia (CML) Reveals New Insights Into Molecular Heterogeneity and Detects Mutations In 12 Different Genes In 82.5% of Cases

Whole Kinome Profiling In Pediatric Acute Leukemia.

Ultra-Deep Next-Generation Sequencing Detects RUNX1 Mutations with Unprecedented Sensitivity and Allows to Monitor Minimal Residual Disease In 116 Samples From MDS and AML Patients

Robust and Sensitive Detection of Insertions, Deletions and Point Mutations In CEBPA , a GC-Rich Content Gene, Using 454 Next-Generation Deep-Sequencing (NGS).

Targeted Next-Generation Sequencing (NGS) Enables a Broad Screening of 95 Molecular Mutations In a One-Step Approach and Detects Recurrent Mutations In AML with a Normal Karyotype In MYH11 and NOTCH1

The Interlaboratory RObustness of Next-Generation Sequencing (IRON) Study: Deep-Sequencing Investigating TET2 , CBL , and KRAS Mutations In 4464 Amplicons by An International Group Involving 8 Laboratories.

Landscape of TET2 Mutations In Acute Myeloid Leukemia (AML): A Next-Generation Sequencing Study Investigating 76 Cases Comprehensively Characterized for Cytogenetics and Other Molecular Markers.

Clinical, Histomorphometric and Radiographic Evaluation of Dental Extraction Sockets Treated with Autologous Stem Cells

Next-Generation Sequencing (NGS) in CMML, MDS and AML Detects Molecular Mutations in Oncogenes and Allows the Identification of Balanced Chromosomal Abnormalities with Extraordinary Sensitivity and Specificity.

Targeted Next-Generation Sequencing (NGS) Enables for the First Time the Detection of Point Mutations, Molecular Insertions and Deletions, as Well as Leukemia-Specific Fusion Genes in AML in a Single Procedure.

Construction of An Outpatient Erythrocytapheresis Program for Pediatric Patients with Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only